Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant gliomaWeiwei Dai, Minfeng Shu, Rong Li et al.|Nature Communications|2024Cited by 67
NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasionRuixin Wu, Minfeng Shu, Chunming Sun et al.|Proceedings of the National Academy of Sciences|2024Cited by 52
Identification and Validation of an Immune-Associated RNA-Binding Proteins Signature to Predict Clinical Outcomes and Therapeutic Responses in Glioma PatientsRuotong Tian, Minfeng Shu, Yimin Li et al.|Cancers|2021Cited by 14
Circadian Regulation Patterns With Distinct Immune Landscapes in Gliomas Aid in the Development of a Risk Model to Predict Prognosis and Therapeutic ResponseRuotong Tian, Minfeng Shu, Yimin Li|Frontiers in Immunology|2022Cited by 12
miR‐221/222 suppression induced by activation of the cAMP/PKA/CREB1 pathway is required for cAMP‐induced bidirectional differentiation of glioma cellsQian Liu, Minfeng Shu, Ruotong Tian et al.|FEBS Letters|2021Cited by 7